The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,300.00
Bid: 1,302.00
Ask: 1,308.00
Change: -22.00 (-1.66%)
Spread: 6.00 (0.461%)
Open: 1,306.00
High: 1,326.00
Low: 1,300.00
Prev. Close: 1,322.00
GAMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of placing in Gamma Communications

22 May 2020 07:00

RNS Number : 7398N
Citigroup Global Markets Limited
22 May 2020
 

 

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA.

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO.596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Press Release

Successful completion of the sale of ordinary shares in Gamma Communications Plc ("Gamma" or the "Company")

22 May 2020

Hoxton Assets Limited ("Hoxton") (the "Seller") hereby announces the successful sale of 1.816 million existing ordinary shares in Gamma ("Placing Shares"), (the "Placing"). The Placing Shares represented approximately 1.9% of Gamma's issued ordinary share capital. Following the sale, Hoxton will retain approximately 10.5% of the Company's issued ordinary share capital in aggregate.

Gross sale proceeds of the offering amounted to approximately £21.3m, equal to £11.75 for each ordinary share. The sale will be settled on 27 May.

Citigroup Global Markets Limited ("Citi") acted as Sole Global Coordinator and Bookrunner in connection with the offering.

The remaining ordinary shares in Gamma that continue to be owned by Hoxton are subject to a 90-day lock-up (subject to waiver by Citi and certain customary exceptions).

Gamma will not receive any proceeds from the Placing.

 

Enquiries:

Citigroup Global Markets Limited

James Fleming

Chuba Ezenwa

Naveen Mittel

Robert Farrington

+44 (0) 20 7500 5000

 

IMPORTANT NOTICE

This announcement is not for publication, distribution or release, directly or indirectly, in or into the United States of America (including its territories and possessions), Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

The Placing Shares may not be offered to the public in any jurisdiction in circumstances which would require the preparation or registration of any prospectus or offering document relating to the Placing Shares in such jurisdiction. No action has been taken by Hoxton or any of its affiliates, that would permit an offering of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such securities in any jurisdiction where action for that purpose is required.

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and, subject to certain exemptions, may not be offered or sold in the United States (as defined in Regulation S under the Securities Act). Neither this document nor the information contained herein constitutes or forms part of an offer to sell or the solicitation of an offer to buy securities in the United States. There will be no public offer of any securities in the United States or in any other jurisdiction.

In member states of the European Economic Area ("EEA") which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement and any offer if made subsequently is directed exclusively at persons who are 'qualified investors' within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression 'Prospectus Directive' means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive" means Directive 2010/73/EU. In the United Kingdom, this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, or (iii) to whom it may otherwise lawfully be communicated.

In connection with any offering of the Placing Shares, Citi and any of its affiliates acting as an investor for their own account may take up as a proprietary position any Placing Shares and in that capacity may retain, purchase or sell for their own account such Placing Shares. In addition they may enter into financing arrangements and swaps with investors in connection with which they may from time to time acquire, hold or dispose of Placing Shares. They do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

Citi, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, is acting on behalf of Hoxton and no one else in connection with any offering of the Placing Shares and will not be responsible to any other person for providing the protections afforded to any of its clients or for providing advice in relation to any offering of the Placing Shares. Citi will not regard any other person as its client in relation to the offering of the Placing Shares.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIUUVVRRBUVURR
Date   Source Headline
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 202411:09 amRNSHolding(s) in Company
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20241:57 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20243:19 pmRNSPublication of Notice of AGM
12th Apr 20243:05 pmRNSDirector/PDMR Shareholding
12th Apr 20243:00 pmRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20249:36 amRNSTransaction in Own Shares
3rd Apr 20247:55 amRNSTransaction in Own Shares
2nd Apr 20246:00 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:02 amRNSShare buyback programme
25th Mar 20247:01 amRNSFinal Results
25th Mar 20247:00 amRNSBoard Change and Committee Composition
22nd Mar 20245:20 pmRNSHolding(s) in Company
14th Mar 20247:30 amRNSDirector/PDMR Shareholding
1st Mar 20242:31 pmRNSTotal Voting Rights
14th Feb 20248:38 amRNSDirector/PDMR Shareholding
13th Feb 20248:00 amRNSSite visit for investors
1st Feb 20241:49 pmRNSTotal Voting Rights
17th Jan 20243:51 pmRNSHolding(s) in Company
16th Jan 20247:00 amRNSScheduled Trading Update
15th Jan 20244:46 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:24 amRNSTotal Voting Rights
28th Dec 20234:10 pmRNSHolding(s) in Company
21st Dec 20235:34 pmRNSHolding(s) in Company
21st Dec 20235:33 pmRNSHolding(s) in Company
13th Dec 20235:35 pmRNSDirector/PDMR Shareholding
13th Dec 202312:34 pmRNSIssue of Equity
5th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20234:13 pmRNSHolding(s) in Company
15th Nov 202310:31 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.